Lucemyra

Product manufactured by Us Worldmeds, Llc

Application Nr Approved Date Route Status External Links
NDA209229 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lucemyra Is Indicated For Mitigation Of Opioid Withdrawal Symptoms To Facilitate Abrupt Opioid Discontinuation In Adults. Lucemyra Is A Central Alpha-2 Adrenergic Agonist Indicated For Mitigation Of Opioid Withdrawal Symptoms To Facilitate Abrupt Opioid Discontinuation In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lofexidine Hydrochloride LOFEXIDINE HYDROCHLORIDE ZINC5626

Comments